Lawitz E
Is this you? Claim this profileThis page collects the articles indexed under the name Lawitz E. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.
Publications 5
- Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
- Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
- Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial
- Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C
- Sofosbuvir for previously untreated chronic hepatitis C infection
Is this you?
Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.
Frequent co-authors
- Jacobson IM 3
- Gane EJ 3
- McHutchison JG 3
- Berg T 2
- Asselah T 2
- Bräu N 2
- Brainard DM 2
- Pearlman B 2
- Hyland RH 2
- Agarwal K 2
- Subramanian GM 2
- Dvory-Sobol H 2